If you've been navigating a PCOS diagnosis and trying to conceive, you've probably come across myo-inositol at some point. Maybe a friend mentioned it, or you found it at the bottom of a TikTok rabbit hole at midnight. Either way, you're right to be curious — because the research on this is actually pretty clear, and it's one of the few supplements in the fertility space that has genuinely earned its reputation.

This isn't another "supercharge your fertility in 30 days" piece. This is a straight-talking breakdown of what myo-inositol is, what the evidence says it can do, why it matters specifically for women with PCOS, and how to use it in a way that's realistic and sustainable. Because you deserve to understand what you're putting in your body — not just be told to take it.

Myo-inositol is a naturally occurring compound found in virtually every cell in the human body. It's often grouped with B vitamins — technically it's classed as a member of the B-complex family — though it's not considered an essential vitamin in the traditional sense. Your body produces some on its own, and you get more from foods like fruits, beans, and wholegrains.

What makes it relevant to fertility — and specifically to PCOS — is what it does inside your cells.

Myo-inositol functions as a signalling molecule. It acts as what scientists call a "second messenger" in the insulin signalling pathway. In simpler terms: it helps your cells actually respond to insulin properly. When that process breaks down — as it often does in women with PCOS — you end up with insulin resistance, and insulin resistance drives many of the hallmark symptoms of the condition: irregular or absent ovulation, elevated androgens (testosterone), weight gain, and disrupted egg quality.

So when you support myo-inositol levels, you're not treating a symptom. You're working on one of the root causes. And that distinction matters.

Research has found that women with PCOS often have a deficiency of inositol in their follicular fluid — the fluid that surrounds and nourishes developing eggs in the ovaries.

One proposed mechanism is that women with PCOS may have a defect in how the body converts myo-inositol into its active form within the ovaries, and may also excrete higher amounts of it in urine. The result is a local deficiency right where it matters most: inside the ovarian environment where eggs develop and mature.

This isn't a minor detail. Follicular fluid composition has a direct impact on oocyte (egg) quality. If the eggs are developing in an environment depleted of a key signalling molecule, the quality of those eggs — and the embryos they could become — is affected.

This helps explain why simply "having PCOS" affects fertility even in women who do manage to ovulate, and why addressing insulin signalling matters beyond just getting a period back.

Myo-inositol supplementation has been shown in multiple clinical studies to support more regular ovulation in women with PCOS, including those who were previously anovulatory (not ovulating at all).

A significant body of research has focused specifically on women with PCOS undergoing fertility treatments — IVF (in vitro fertilisation) and ICSI (intracytoplasmic sperm injection). A meta-analysis looking across multiple randomised controlled trials found that myo-inositol supplementation was associated with:

• Improved clinical pregnancy rates
• Reduced miscarriage rates
• A higher proportion of high-quality (Grade 1) embryos
• Fewer degenerated or immature oocytes retrieved
• A reduction in the amount of stimulation medication required during IVF cycles

[Unfer et al., meta-analysis of myo-inositol in ART cycles — multiple publications from 2011–2017]

That last point is worth pausing on. Lower doses of ovarian stimulation drugs needed during IVF isn't just about reducing cost. It's associated with a lower risk of ovarian hyperstimulation syndrome (OHSS) — a potentially serious complication that is disproportionately common in women with PCOS undergoing stimulation protocols.

If you're preparing for IVF or ICSI, that's information worth having.

Myo-inositol supports egg quality by improving the hormonal and metabolic environment in which eggs develop — particularly FSH (follicle-stimulating hormone) signalling and insulin sensitivity within the ovaries.

Here's the mechanism, broken down simply:

FSH is the hormone responsible for stimulating egg growth in the ovaries. For FSH to do its job effectively, cells in the ovary need to respond to it properly. This response depends, in part, on inositol-based signalling pathways. When inositol is deficient, FSH signalling becomes less efficient — meaning eggs may not develop as well as they should, or may not reach full maturity.

At the same time, insulin resistance in the ovarian environment can drive up androgen (testosterone) levels and disrupt the careful hormonal choreography that healthy egg development depends on. By improving insulin sensitivity at the cellular level, myo-inositol helps restore that balance.

The practical result, seen consistently across studies, is a higher percentage of mature, high-quality eggs — the kind that are more likely to fertilise successfully and develop into viable embryos. [Papaleo et al., 2007; Ciotta et al., 2011; Unfer et al., 2011]

Yes — and this is actually where I think the conversation gets really important.

Much of the early research was conducted in the context of assisted reproduction, but that doesn't mean myo-inositol is only relevant if you're preparing for IVF. The underlying mechanisms — improved insulin sensitivity, better ovarian function, more regular ovulation — apply to all women with PCOS, regardless of how they're trying to conceive.

For women with PCOS trying to conceive naturally, the evidence supports myo-inositol as a way to:

• Restore or regulate menstrual cycles
• Support more consistent ovulation
• Improve the hormonal profile (lower androgens, better LH/FSH ratio)
• Reduce insulin resistance, which has downstream benefits for cycle regularity and fertility

Several studies have shown that women with PCOS who were not ovulating regularly began ovulating after three months of myo-inositol supplementation — without any additional fertility medications. [Gerli et al., 2007; Raffone et al., 2010]

If you've been told your PCOS means conception will be difficult, that's worth knowing. It doesn't mean it will be easy. But it means there's something specific and evidence-based you can do to support your body.

This is one I feel personally.

Miscarriage risk is elevated in women with PCOS, partly because insulin resistance and the hormonal imbalances associated with PCOS can affect early embryo development and implantation. Elevated LH levels — common in PCOS — have also been associated with a higher miscarriage risk.

The meta-analysis mentioned earlier found that myo-inositol supplementation was associated with reduced miscarriage rates in women undergoing IVF — a finding that, while not definitive, is consistent with the mechanism: better egg quality and a more balanced hormonal environment before and during the early stages of pregnancy.

This isn't a guarantee. Nothing in fertility is. But it adds another dimension to why myo-inositol is considered one of the most important supplements for women with PCOS who are trying to conceive or preparing for fertility treatment.

The most studied and consistently used dose of myo-inositol in clinical research is 4g per day, typically divided into two doses and taken alongside folic acid.

Some studies used higher doses — up to 12g per day — but 4g is the benchmark from the majority of trials, and it's the dose used in the research showing improvements in clinical pregnancy rates and embryo quality.

The folic acid pairing matters. Most trials administered myo-inositol alongside folic acid — typically 400mcg per day — and the two appear to work synergistically in supporting reproductive outcomes. Folic acid has its own established role in preventing neural tube defects and supporting early fetal development, so including it is both evidence-based and standard preconception practice.

In terms of timing:

• Some trials supplemented for three months before and during controlled ovarian stimulation
• Others used it from the first day of the cycle until two weeks after embryo transfer
• For natural conception, a minimum of three months of consistent supplementation is generally recommended before expecting to see cycle changes

The key word there is consistent. Myo-inositol isn't a quick fix — it works by gradually improving the cellular environment over time. That's not a flaw. That's how root-cause support works. [Unfer et al.; Papaleo et al.; Raffone et al., various publications 2007–2019]

This is exactly why myo-inositol is the foundation of MyOva's Preconception Supplement.

When I was doing my own research after my losses, I kept coming back to this compound. The evidence was solid. The mechanism made sense. And when I tried to find a quality, well-formulated version in the UK, I couldn't. That frustration — that moment of "why is this so hard?" — is what sparked MyOva.

Our Preconception Supplement was formulated to give your body what the research actually supports — not a scattershot of trendy ingredients, but a comprehensive stack built around the nutrients that matter most for hormonal and reproductive health.

Alongside myo-inositol, it contains:

• Folate (the bioavailable form of folic acid) — essential for preconception and early pregnancy
• Coenzyme Q10 (as Ubiquinol) — the most bioavailable form of CoQ10, which has significant evidence for supporting egg quality and mitochondrial function
• N-Acetyl Cysteine (NAC) — a powerful antioxidant shown in studies to support ovulation and reduce androgen levels in PCOS
• Alpha Lipoic Acid — supports insulin sensitivity and reduces oxidative stress in follicular fluid
• L-Arginine — supports blood flow to the ovaries and uterine lining
• Vitamin D3 — low levels are strongly associated with PCOS and reduced fertility
• Zinc, Selenium, and Chromium — critical minerals for insulin regulation, thyroid function, and egg maturation
• B vitamins (B1, B2, B3, B6, B12, Biotin, Pantothenic Acid) — supporting energy metabolism and hormonal balance
• Vitamins C and E + Beta-carotene — antioxidant protection for eggs during development
• Magnesium, Iron, Iodine, and Copper — foundational minerals for cycle regularity and reproductive health

This isn't a supplement with a celebrity on the label. It's a formulation grounded in evidence, designed for women who want to understand what they're taking and why.

Most studies show meaningful improvements in ovulation and cycle regularity after three months of consistent supplementation — though some women notice changes sooner.

Three months is the rough minimum to see shifts in:

• Cycle regularity
• Ovulation (if you're tracking with BBT or LH strips)
• Hormonal markers on blood tests (LH/FSH ratio, testosterone)

The reason it takes this long is biological: the egg development cycle (folliculogenesis) takes approximately 90 days. You're not just treating symptoms — you're improving the environment that eggs develop in over the full maturation window.

If you're not tracking your cycle already, now is the time to start. Apps like Natural Cycles or a simple BBT thermometer combined with LH strips will help you see what's actually changing — and give you something concrete to bring to your next GP or consultant appointment.

Myo-inositol is generally well tolerated at doses used in research (up to 4g/day). The most commonly reported side effects in studies were mild GI symptoms — bloating, nausea, loose stools — particularly when starting, and typically at higher doses.

Starting with a lower dose and building up over two to three weeks can help minimise this.

If you're currently taking metformin, it's worth mentioning myo-inositol to your doctor before starting. Both work on insulin sensitivity — they have complementary mechanisms, and some research has looked at combined use, but your prescribing clinician should be aware. The same applies if you're taking any medication for blood sugar management.

Myo-inositol has not been shown to interact negatively with standard IVF protocols, and is frequently recommended by fertility specialists and nutritional practitioners as part of IVF preparation — but always inform your clinic of any supplements you're taking.

This matters, and it would be disingenuous not to address it.

The studies on myo-inositol in fertility are largely positive, but they come with caveats:

• Many trials were relatively small
• Some lacked proper blinding (so placebo effects can't be entirely ruled out)
• The majority of participants were Caucasian women, which limits how broadly the findings generalise
• There's variability in the doses and durations used across studies, making direct comparison difficult
• Most research has focused on women with PCOS; evidence in other fertility populations is more limited

None of this means myo-inositol doesn't work. It means the science is still developing, which is true of almost everything in reproductive medicine. The mechanistic rationale is solid, the clinical data is consistently encouraging, and the safety profile is good. That's a reasonable basis for including it in a preconception plan — particularly for women with PCOS — but it should be part of a broader approach, not the entire strategy.

Nutrition, stress, sleep, movement, and working with a knowledgeable healthcare provider all matter. Myo-inositol is a meaningful piece of the picture. It's not the whole picture.

Myo-inositol improves how cells respond to insulin and FSH (follicle-stimulating hormone), supporting better egg maturation and more regular ovulation. In women with PCOS, it helps address the insulin resistance that often disrupts the menstrual cycle and impairs egg quality. Studies show it can improve ovulation rates, embryo quality, and clinical pregnancy rates, particularly in the context of IVF.

The most commonly researched and recommended dose is 4g per day, typically divided into two doses of 2g, taken alongside folic acid. This is the dose used in the majority of trials showing improvements in ovulation and pregnancy outcomes. Most women take it for a minimum of three months before expecting to see meaningful changes in their cycle or hormonal markers.

Yes. While much of the original research was conducted in IVF settings, the underlying mechanisms — improved insulin sensitivity, better ovarian signalling, more regular ovulation — apply to all women with PCOS, including those trying to conceive naturally. Studies have shown that myo-inositol can help restore ovulation in women with PCOS who were previously not ovulating at all.

Most research has focused on supplementation in the preconception period and early stages of fertility treatment. Some studies have continued myo-inositol into the first trimester with no adverse effects noted. However, if you're pregnant or have just found out you're pregnant, discuss ongoing supplementation with your midwife or GP. In the MyOva Preconception Supplement, myo-inositol is formulated alongside folate and other nutrients relevant to preconception — consult your healthcare provider regarding continuing any supplement into pregnancy.

Most clinical studies show meaningful improvements in cycle regularity and ovulation after three months of consistent supplementation. This aligns with the approximately 90-day window of egg development (folliculogenesis) — meaning you're influencing the environment eggs mature in across their full development cycle. Some women notice changes earlier. Consistent daily supplementation and cycle tracking will help you see what's shifting.

Myo-inositol isn't a miracle supplement, and I'll never tell you it is.

But for women with PCOS — particularly those dealing with insulin resistance, irregular cycles, poor ovarian response, or preparing for IVF — it is one of the most evidence-backed nutritional interventions available. The research is consistent. The mechanism is understood. The safety profile is strong.

What I wish someone had told me, years before I figured this out for myself: you don't have to accept that PCOS automatically means your fertility is out of your hands. There is something specific and meaningful you can do. Understanding your hormones, supporting your insulin sensitivity, and giving your eggs the best developmental environment possible — these are things within your control.

You're not powerless. A diagnosis is a starting point. Not a verdict.

If you'd like to explore whether the MyOva Preconception Supplement is right for where you are in your journey, it's formulated with myo-inositol at its core — alongside the comprehensive nutritional support that the preconception period deserves.

• PCOS and Insulin Resistance: What's Actually Going On in Your Body
• How to Improve Egg Quality: What the Evidence Actually Says
• Tracking Your Cycle with PCOS: A Practical Guide
• The Truth About PCOS and Fertility: What Your GP Might Not Have Told You
• Preparing for IVF with PCOS: How to Support Your Body Before You Start

1. Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology. 2012;28(7):509–515.

2. Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecological Endocrinology. 2007;23(12):700–703.

3. Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. European Review for Medical and Pharmacological Sciences. 2007;11(5):347–354.

4. Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecological Endocrinology. 2010;26(4):275–280.

5. Ciotta L, Stracquadanio M, La Marca I, et al. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. European Review for Medical and Pharmacological Sciences. 2011;15(5):509–514.

6. Brusco GF, Mariani M. Inositol: effects on oocyte quality in patients undergoing ICSI. An open study. European Review for Medical and Pharmacological Sciences. 2013;17(22):3095–3102.

7. Pkhaladze L, Barbakadze L, Kvashilava N. Myo-inositol in the treatment of teenagers affected by PCOS. International Journal of Endocrinology. 2016;2016:1473981.

8. Artini PG, Di Berardino OM, Papini F, et al. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. Gynecological Endocrinology. 2013;29(4):375–379.

9. Isabella R, Raffone E. Does ovary need D-chiro-inositol? Journal of Ovarian Research. 2012;5(1):14.

10. Colazingari S, Treglia M, Najjar R, Bevilacqua A. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes. Archives of Gynecology and Obstetrics. 2013;288(6):1405–1411.